3.26.1 html 121 327 2 false 46 0 false 10 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://vynetherapeutics.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00100 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://vynetherapeutics.com/role/StatementConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 00105 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://vynetherapeutics.com/role/StatementConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 00200 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Sheet http://vynetherapeutics.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Statements 4 false false R5.htm 00205 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Parenthetical) Sheet http://vynetherapeutics.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLossParenthetical CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Parenthetical) Statements 5 false false R6.htm 00300 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY Sheet http://vynetherapeutics.com/role/StatementConsolidatedStatementsOfChangesInShareholdersEquity CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY Statements 6 false false R7.htm 00400 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://vynetherapeutics.com/role/StatementConsolidatedStatementsOfCashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 7 false false R8.htm 10101 - Disclosure - NATURE OF OPERATIONS Sheet http://vynetherapeutics.com/role/DisclosureNatureOfOperations NATURE OF OPERATIONS Notes 8 false false R9.htm 10201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES Sheet http://vynetherapeutics.com/role/DisclosureSignificantAccountingPolicies SIGNIFICANT ACCOUNTING POLICIES Notes 9 false false R10.htm 10301 - Disclosure - STRATEGIC AGREEMENTS Sheet http://vynetherapeutics.com/role/DisclosureStrategicAgreements STRATEGIC AGREEMENTS Notes 10 false false R11.htm 10401 - Disclosure - DISCONTINUED OPERATIONS Sheet http://vynetherapeutics.com/role/DisclosureDiscontinuedOperations DISCONTINUED OPERATIONS Notes 11 false false R12.htm 10501 - Disclosure - FAIR VALUE MEASUREMENTS Sheet http://vynetherapeutics.com/role/DisclosureFairValueMeasurements FAIR VALUE MEASUREMENTS Notes 12 false false R13.htm 10601 - Disclosure - MARKETABLE SECURITIES Sheet http://vynetherapeutics.com/role/DisclosureMarketableSecurities MARKETABLE SECURITIES Notes 13 false false R14.htm 10701 - Disclosure - PROPERTY AND EQUIPMENT Sheet http://vynetherapeutics.com/role/DisclosurePropertyAndEquipment PROPERTY AND EQUIPMENT Notes 14 false false R15.htm 10801 - Disclosure - ACCRUED EXPENSES Sheet http://vynetherapeutics.com/role/DisclosureAccruedExpenses ACCRUED EXPENSES Notes 15 false false R16.htm 10901 - Disclosure - OPERATING LEASE Sheet http://vynetherapeutics.com/role/DisclosureOperatingLease OPERATING LEASE Notes 16 false false R17.htm 11001 - Disclosure - EMPLOYEE SAVINGS PLAN Sheet http://vynetherapeutics.com/role/DisclosureEmployeeSavingsPlan EMPLOYEE SAVINGS PLAN Notes 17 false false R18.htm 11101 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://vynetherapeutics.com/role/DisclosureCommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 18 false false R19.htm 11201 - Disclosure - SHAREHOLDERS' EQUITY Sheet http://vynetherapeutics.com/role/DisclosureShareholdersEquity SHAREHOLDERS' EQUITY Notes 19 false false R20.htm 11301 - Disclosure - SHARE-BASED COMPENSATION Sheet http://vynetherapeutics.com/role/DisclosureShareBasedCompensation SHARE-BASED COMPENSATION Notes 20 false false R21.htm 11401 - Disclosure - INCOME TAX Sheet http://vynetherapeutics.com/role/DisclosureIncomeTax INCOME TAX Notes 21 false false R22.htm 11501 - Disclosure - SEGMENT INFORMATION Sheet http://vynetherapeutics.com/role/DisclosureSegmentInformation SEGMENT INFORMATION Notes 22 false false R23.htm 20202 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://vynetherapeutics.com/role/DisclosureSignificantAccountingPoliciesPolicies SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 23 false false R24.htm 30203 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://vynetherapeutics.com/role/DisclosureSignificantAccountingPoliciesTables SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://vynetherapeutics.com/role/DisclosureSignificantAccountingPolicies 24 false false R25.htm 30303 - Disclosure - DISCONTINUED OPERATIONS (Tables) Sheet http://vynetherapeutics.com/role/DisclosureDiscontinuedOperationsTables DISCONTINUED OPERATIONS (Tables) Tables http://vynetherapeutics.com/role/DisclosureDiscontinuedOperations 25 false false R26.htm 30503 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) Sheet http://vynetherapeutics.com/role/DisclosureFairValueMeasurementsTables FAIR VALUE MEASUREMENTS (Tables) Tables http://vynetherapeutics.com/role/DisclosureFairValueMeasurements 26 false false R27.htm 30603 - Disclosure - MARKETABLE SECURITIES (Tables) Sheet http://vynetherapeutics.com/role/DisclosureMarketableSecuritiesTables MARKETABLE SECURITIES (Tables) Tables http://vynetherapeutics.com/role/DisclosureMarketableSecurities 27 false false R28.htm 30703 - Disclosure - PROPERTY AND EQUIPMENT (Tables) Sheet http://vynetherapeutics.com/role/DisclosurePropertyAndEquipmentTables PROPERTY AND EQUIPMENT (Tables) Tables http://vynetherapeutics.com/role/DisclosurePropertyAndEquipment 28 false false R29.htm 30803 - Disclosure - ACCRUED EXPENSES (Tables) Sheet http://vynetherapeutics.com/role/DisclosureAccruedExpensesTables ACCRUED EXPENSES (Tables) Tables http://vynetherapeutics.com/role/DisclosureAccruedExpenses 29 false false R30.htm 30903 - Disclosure - OPERATING LEASE (Tables) Sheet http://vynetherapeutics.com/role/DisclosureOperatingLeaseTables OPERATING LEASE (Tables) Tables http://vynetherapeutics.com/role/DisclosureOperatingLease 30 false false R31.htm 31203 - Disclosure - SHAREHOLDERS' EQUITY (Tables) Sheet http://vynetherapeutics.com/role/DisclosureShareholdersEquityTables SHAREHOLDERS' EQUITY (Tables) Tables http://vynetherapeutics.com/role/DisclosureShareholdersEquity 31 false false R32.htm 31303 - Disclosure - SHARE-BASED COMPENSATION (Tables) Sheet http://vynetherapeutics.com/role/DisclosureShareBasedCompensationTables SHARE-BASED COMPENSATION (Tables) Tables http://vynetherapeutics.com/role/DisclosureShareBasedCompensation 32 false false R33.htm 31403 - Disclosure - INCOME TAX (Tables) Sheet http://vynetherapeutics.com/role/DisclosureIncomeTaxTables INCOME TAX (Tables) Tables http://vynetherapeutics.com/role/DisclosureIncomeTax 33 false false R34.htm 31503 - Disclosure - SEGMENT INFORMATION (Tables) Sheet http://vynetherapeutics.com/role/DisclosureSegmentInformationTables SEGMENT INFORMATION (Tables) Tables http://vynetherapeutics.com/role/DisclosureSegmentInformation 34 false false R35.htm 40101 - Disclosure - NATURE OF OPERATIONS (Details) Sheet http://vynetherapeutics.com/role/DisclosureNatureOfOperationsDetails NATURE OF OPERATIONS (Details) Details http://vynetherapeutics.com/role/DisclosureNatureOfOperations 35 false false R36.htm 40201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details) Sheet http://vynetherapeutics.com/role/DisclosureSignificantAccountingPoliciesNarrativeDetails SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details) Details 36 false false R37.htm 40202 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Schedule of Estimated Useful Life (Details) Sheet http://vynetherapeutics.com/role/DisclosureSignificantAccountingPoliciesScheduleOfEstimatedUsefulLifeDetails SIGNIFICANT ACCOUNTING POLICIES - Schedule of Estimated Useful Life (Details) Details 37 false false R38.htm 40203 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Schedule of Antidilutive Equity Awards Not Included in the Calculation of EPS (Details) Sheet http://vynetherapeutics.com/role/DisclosureSignificantAccountingPoliciesScheduleOfAntidilutiveEquityAwardsNotIncludedInCalculationOfEpsDetails SIGNIFICANT ACCOUNTING POLICIES - Schedule of Antidilutive Equity Awards Not Included in the Calculation of EPS (Details) Details 38 false false R39.htm 40301 - Disclosure - STRATEGIC AGREEMENTS (Details) Sheet http://vynetherapeutics.com/role/DisclosureStrategicAgreementsDetails STRATEGIC AGREEMENTS (Details) Details http://vynetherapeutics.com/role/DisclosureStrategicAgreements 39 false false R40.htm 40401 - Disclosure - DISCONTINUED OPERATIONS - Schedule of Discontinued Operations of the MST Franchise (Details) Sheet http://vynetherapeutics.com/role/DisclosureDiscontinuedOperationsScheduleOfDiscontinuedOperationsOfMstFranchiseDetails DISCONTINUED OPERATIONS - Schedule of Discontinued Operations of the MST Franchise (Details) Details 40 false false R41.htm 40402 - Disclosure - DISCONTINUED OPERATIONS - Narrative (Details) Sheet http://vynetherapeutics.com/role/DisclosureDiscontinuedOperationsNarrativeDetails DISCONTINUED OPERATIONS - Narrative (Details) Details 41 false false R42.htm 40501 - Disclosure - FAIR VALUE MEASUREMENT (Details) Sheet http://vynetherapeutics.com/role/DisclosureFairValueMeasurementDetails FAIR VALUE MEASUREMENT (Details) Details http://vynetherapeutics.com/role/DisclosureFairValueMeasurementsTables 42 false false R43.htm 40601 - Disclosure - MARKETABLE SECURITIES - Schedule of Marketable Securities (Details) Sheet http://vynetherapeutics.com/role/DisclosureMarketableSecuritiesScheduleOfMarketableSecuritiesDetails MARKETABLE SECURITIES - Schedule of Marketable Securities (Details) Details 43 false false R44.htm 40602 - Disclosure - MARKETABLE SECURITIES - Schedule of Fair Value, Cost and Gross Unrealized Holding Gains of Securities Owned (Details) Sheet http://vynetherapeutics.com/role/DisclosureMarketableSecuritiesScheduleOfFairValueCostAndGrossUnrealizedHoldingGainsOfSecuritiesOwnedDetails MARKETABLE SECURITIES - Schedule of Fair Value, Cost and Gross Unrealized Holding Gains of Securities Owned (Details) Details 44 false false R45.htm 40603 - Disclosure - MARKETABLE SECURITIES - Narrative (Details) Sheet http://vynetherapeutics.com/role/DisclosureMarketableSecuritiesNarrativeDetails MARKETABLE SECURITIES - Narrative (Details) Details 45 false false R46.htm 40701 - Disclosure - PROPERTY AND EQUIPMENT - Schedule of Property and Equipment (Details) Sheet http://vynetherapeutics.com/role/DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails PROPERTY AND EQUIPMENT - Schedule of Property and Equipment (Details) Details 46 false false R47.htm 40702 - Disclosure - PROPERTY AND EQUIPMENT - Narrative (Details) Sheet http://vynetherapeutics.com/role/DisclosurePropertyAndEquipmentNarrativeDetails PROPERTY AND EQUIPMENT - Narrative (Details) Details 47 false false R48.htm 40801 - Disclosure - ACCRUED EXPENSES (Details) Sheet http://vynetherapeutics.com/role/DisclosureAccruedExpensesDetails ACCRUED EXPENSES (Details) Details http://vynetherapeutics.com/role/DisclosureAccruedExpensesTables 48 false false R49.htm 40901 - Disclosure - OPERATING LEASE - Narrative (Details) Sheet http://vynetherapeutics.com/role/DisclosureOperatingLeaseNarrativeDetails OPERATING LEASE - Narrative (Details) Details 49 false false R50.htm 40902 - Disclosure - OPERATING LEASE - Schedule of Operating Lease Cost (Details) Sheet http://vynetherapeutics.com/role/DisclosureOperatingLeaseScheduleOfOperatingLeaseCostDetails OPERATING LEASE - Schedule of Operating Lease Cost (Details) Details 50 false false R51.htm 40903 - Disclosure - OPERATING LEASE - Schedule of Cash Paid for Lease Liabilities (Details) Sheet http://vynetherapeutics.com/role/DisclosureOperatingLeaseScheduleOfCashPaidForLeaseLiabilitiesDetails OPERATING LEASE - Schedule of Cash Paid for Lease Liabilities (Details) Details 51 false false R52.htm 40904 - Disclosure - OPERATING LEASE - Schedule of Supplemental Information Related to Leases (Details) Sheet http://vynetherapeutics.com/role/DisclosureOperatingLeaseScheduleOfSupplementalInformationRelatedToLeasesDetails OPERATING LEASE - Schedule of Supplemental Information Related to Leases (Details) Details 52 false false R53.htm 41001 - Disclosure - EMPLOYEE SAVINGS PLAN (Details) Sheet http://vynetherapeutics.com/role/DisclosureEmployeeSavingsPlanDetails EMPLOYEE SAVINGS PLAN (Details) Details http://vynetherapeutics.com/role/DisclosureEmployeeSavingsPlan 53 false false R54.htm 41101 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) Sheet http://vynetherapeutics.com/role/DisclosureCommitmentsAndContingenciesDetails COMMITMENTS AND CONTINGENCIES (Details) Details http://vynetherapeutics.com/role/DisclosureCommitmentsAndContingencies 54 false false R55.htm 41201 - Disclosure - SHAREHOLDERS' EQUITY - Narrative (Details) Sheet http://vynetherapeutics.com/role/DisclosureShareholdersEquityNarrativeDetails SHAREHOLDERS' EQUITY - Narrative (Details) Details 55 false false R56.htm 41202 - Disclosure - SHAREHOLDERS' EQUITY - Schedule of Common Stock for Future Issuance (Details) Sheet http://vynetherapeutics.com/role/DisclosureShareholdersEquityScheduleOfCommonStockForFutureIssuanceDetails SHAREHOLDERS' EQUITY - Schedule of Common Stock for Future Issuance (Details) Details 56 false false R57.htm 41301 - Disclosure - SHARE-BASED COMPENSATION - Narrative (Details) Sheet http://vynetherapeutics.com/role/DisclosureShareBasedCompensationNarrativeDetails SHARE-BASED COMPENSATION - Narrative (Details) Details 57 false false R58.htm 41302 - Disclosure - SHARE-BASED COMPENSATION - Schedule of Options and RSU Grants (Details) Sheet http://vynetherapeutics.com/role/DisclosureShareBasedCompensationScheduleOfOptionsAndRsuGrantsDetails SHARE-BASED COMPENSATION - Schedule of Options and RSU Grants (Details) Details 58 false false R59.htm 41303 - Disclosure - SHARE-BASED COMPENSATION - Schedule of Underlying Data Used for Computing the Fair Value of the Options (Details) Sheet http://vynetherapeutics.com/role/DisclosureShareBasedCompensationScheduleOfUnderlyingDataUsedForComputingFairValueOfOptionsDetails SHARE-BASED COMPENSATION - Schedule of Underlying Data Used for Computing the Fair Value of the Options (Details) Details 59 false false R60.htm 41304 - Disclosure - SHARE-BASED COMPENSATION - Schedule of Stock Option Activity (Details) Sheet http://vynetherapeutics.com/role/DisclosureShareBasedCompensationScheduleOfStockOptionActivityDetails SHARE-BASED COMPENSATION - Schedule of Stock Option Activity (Details) Details 60 false false R61.htm 41305 - Disclosure - SHARE-BASED COMPENSATION - Schedule of RSUs Activity (Details) Sheet http://vynetherapeutics.com/role/DisclosureShareBasedCompensationScheduleOfRsusActivityDetails SHARE-BASED COMPENSATION - Schedule of RSUs Activity (Details) Details 61 false false R62.htm 41306 - Disclosure - SHARE-BASED COMPENSATION - Schedule of Share-based Compensation (Details) Sheet http://vynetherapeutics.com/role/DisclosureShareBasedCompensationScheduleOfShareBasedCompensationDetails SHARE-BASED COMPENSATION - Schedule of Share-based Compensation (Details) Details 62 false false R63.htm 41401 - Disclosure - INCOME TAX - Schedule of Income (Loss) Before Income Tax Taxes and Current Tax (Benefit) Expense (Details) Sheet http://vynetherapeutics.com/role/DisclosureIncomeTaxScheduleOfIncomeLossBeforeIncomeTaxTaxesAndCurrentTaxBenefitExpenseDetails INCOME TAX - Schedule of Income (Loss) Before Income Tax Taxes and Current Tax (Benefit) Expense (Details) Details 63 false false R64.htm 41402 - Disclosure - INCOME TAX - Schedule of Income Tax Reconciliation (Details) Sheet http://vynetherapeutics.com/role/DisclosureIncomeTaxScheduleOfIncomeTaxReconciliationDetails INCOME TAX - Schedule of Income Tax Reconciliation (Details) Details 64 false false R65.htm 41403 - Disclosure - INCOME TAX - Narrative (Details) Sheet http://vynetherapeutics.com/role/DisclosureIncomeTaxNarrativeDetails INCOME TAX - Narrative (Details) Details 65 false false R66.htm 41404 - Disclosure - INCOME TAX - Schedule of Deferred Income Taxes (Details) Sheet http://vynetherapeutics.com/role/DisclosureIncomeTaxScheduleOfDeferredIncomeTaxesDetails INCOME TAX - Schedule of Deferred Income Taxes (Details) Details 66 false false R67.htm 41405 - Disclosure - INCOME TAX - Schedule of Activity of the Company Unrecognized Tax Benefits (Details) Sheet http://vynetherapeutics.com/role/DisclosureIncomeTaxScheduleOfActivityOfCompanyUnrecognizedTaxBenefitsDetails INCOME TAX - Schedule of Activity of the Company Unrecognized Tax Benefits (Details) Details 67 false false R68.htm 41501 - Disclosure - SEGMENT INFORMATION (Details) Sheet http://vynetherapeutics.com/role/DisclosureSegmentInformationDetails SEGMENT INFORMATION (Details) Details http://vynetherapeutics.com/role/DisclosureSegmentInformationTables 68 false false R69.htm 995210 - Document - Submission Sheet http://xbrl.sec.gov/ffd/role/document/submissionTable Submission Cover 69 true false R70.htm 995211 - Document - Offerings Sheet http://xbrl.sec.gov/ffd/role/document/feesOfferingTable Offerings Cover 70 false false R71.htm 995215 - Document - Fees Summary Sheet http://xbrl.sec.gov/ffd/role/document/feesSummaryTable Fees Summary Cover 71 false false All Reports Book All Reports vyne-20251231.xsd vyne-20251231_cal.xml vyne-20251231_def.xml vyne-20251231_lab.xml vyne-20251231_pre.xml vyne-20251231xs4a.htm vyne-20251231xexfees.htm vyne-20251231xs4a007.jpg vyne-20251231xs4a008.jpg vyne-20251231xs4a019.jpg vyne-20251231xs4a020.jpg vyne-20251231xs4a024.jpg vyne-20251231xs4a025.jpg vyne-20251231xs4a026.jpg vyne-20251231xs4a027.jpg vyne-20251231xs4a028.jpg http://fasb.org/us-gaap/2025 http://xbrl.sec.gov/dei/2025 http://xbrl.sec.gov/dei/2026 http://xbrl.sec.gov/ffd/2026 true true